Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menlo Therapeutics Inc.

menlotherapeutics.com

Latest From Menlo Therapeutics Inc.

Cara’s Korsuva Impresses Against Pruritus In Hemodialysis Patients

Cara Therapeutics and licensee Vifor Pharma have released positive topline data from the KALM-2 study in chronic kidney disease patients with moderate-to-severe pruritus undergoing hemodialysis, using a first-in-class selective kappa opioid receptor agonist which does not enter the CNS.

Dermatology Clinical Trials

Menlo’s Setback Not Expected To Affect Results In Lead Pruritus Indication

With Foamix merger closing soon, Menlo’s serlopitant failed a Phase II trial in chronic pruritus of unknown origin, but the firm said a Phase III program in prurigo nodularis shouldn’t be affected. Its share in the new company is contingent on the PN data.

Clinical Trials Business Strategies

Keeping Track: Vascepa Adds CV Risk Reduction Claim And Submissions Pour Into FDA

The latest drug development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Deal Watch: Allergan Keeps After Hair Loss With Exicure Deal

Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Respiratory, Pulmonary
  • Alias(es)
  • Tigercat Pharma Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Menlo Therapeutics Inc.
  • Senior Management
  • Steven Basta, CEO
    Kristine M Ball, SVP, Corp. Strategy & CFO
    Paul Kwon, MD, CSO
    Xiaoming Zhang, PhD, SVP, Non-Clinical & CMC
    Mary C Spellman, MD, CMO
    Danine Summers, SVP, Medical Affairs
  • Contact Info
  • Menlo Therapeutics Inc.
    Phone: (650) 486-1416
    200 Cardinal Way
    Redwood City, CA 94063
    USA
UsernamePublicRestriction

Register